These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 26733461)

  • 1. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
    Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
    Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
    Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
    Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
    Satoh K; Yoshida N; Imaizumi K; Yajima M; Wakui H; Sawada K; Komatsuda A
    Am J Med Sci; 2009 Oct; 338(4):334-5. PubMed ID: 19745701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
    Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
    Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
    Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
    Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-Related Lymphoproliferative Disorder Presenting with Severe Swelling of the Elbow Joint: A Case Report.
    Hatano T; Ohishi M; Yoshimoto G; Yamauchi M; Maekawa A; Yamamoto H; Oda Y; Endo M; Bekki H; Matsunobu T; Nakashima Y; Okazaki K; Fukushi JI; Oyamada A; Iwamoto Y
    JBJS Case Connect; 2017; 7(3):e65. PubMed ID: 29252894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
    Ishigaki S; Masaoka T; Kameyama H; Kawaida M; Kameyama K; Mori T; Kanai T
    Intern Med; 2018; 57(22):3249-3254. PubMed ID: 30429434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
    Toyonaga H; Fukushima M; Shimeno N; Inokuma T
    BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
    Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
    J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
    Hirata C; Kenzaka T; Akita H
    J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
    Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
    BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
    Kuramoto R; Hirata K; Takei T; Oridate N; Suzuki S; Yamada Y; Imamura M; Tamaki N
    Clin Nucl Med; 2011 Jul; 36(7):582-3. PubMed ID: 21637066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
    Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
    Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
    Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
    Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
    Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
    Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
    Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
    Furukawa S; Oobu K; Moriyama M; Kawano S; Sako S; Hayashida JN; Matsubara R; Ogata KI; Kiyoshima T; Nakamura S
    Intern Med; 2018 Feb; 57(4):575-581. PubMed ID: 29225245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of iatrogenic immunodeficiency-associated lymphoproliferative disease in a patient treated with methotrexate for rheumatoid arthritis for 9 consecutive years, which Showed natural remission after discontinuation of MTX therapy].
    Kaneko J; Gozu K; Aoyagi H; Matsui T; Yoshida T; Hasegawa K; Isogai J; Maejima S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2454-6. PubMed ID: 24394142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
    Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
    Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.